InterCure Ltd. (NASDAQ:INCR) Short Interest Update

InterCure Ltd. (NASDAQ:INCR) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 16,200 shares, a growth of 16.5% from the October 31st total of 13,900 shares. Based on an average daily volume of 32,200 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.1% of the company’s shares are short sold.

Hedge Funds Weigh In On InterCure

Several institutional investors and hedge funds have recently added to or reduced their stakes in INCR. Tidal Investments LLC bought a new stake in shares of InterCure in the first quarter worth $883,000. AdvisorShares Investments LLC bought a new stake in shares of InterCure in the 2nd quarter valued at about $218,000. Renaissance Technologies LLC increased its stake in shares of InterCure by 30.9% in the second quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock valued at $91,000 after buying an additional 10,700 shares during the period. Jane Street Group LLC bought a new position in shares of InterCure during the third quarter worth about $49,000. Finally, Virtu Financial LLC acquired a new position in shares of InterCure in the third quarter worth approximately $43,000. 8.34% of the stock is currently owned by institutional investors and hedge funds.

InterCure Price Performance

NASDAQ:INCR opened at $1.31 on Tuesday. The stock’s 50-day moving average is $1.64 and its 200-day moving average is $2.06. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.15 and a current ratio of 1.78. InterCure has a 1-year low of $1.17 and a 1-year high of $3.72.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.